These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6284362)

  • 1. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
    Gaynon PS; Baum ES; Krivit W; Hammond D
    Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
    Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of VM-26 in acute leukemia, neuroblastoma, and other refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Bleyer WA; Krivit W; Chard RL; Hammond D
    Cancer Treat Rep; 1979 Jun; 63(6):977-81. PubMed ID: 380803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II clinical trial of prednimustine. Clinical screening cooperative group of E.O.R.T.C.
    Biomedicine; 1977 Jun; 27(4):158-61. PubMed ID: 329910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
    Juul K; Sørensen P; Pedersen-Bjergaard J; Jensen MK
    Scand J Haematol; 1979 Nov; 23(5):388-92. PubMed ID: 396664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
    Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
    Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
    Finklestein JZ; Higgins G; Krivit W; Hammond D
    Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of intravenous allopurinol (NSC-1390) in pediatric neoplasia.
    Donnenberg A; Holton CP; Mayer CM; Phillips LK
    Cancer Chemother Rep; 1974; 58(5 Pt 1):737-9. PubMed ID: 4371949
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II study of VP-16-213 in childhood malignant disease: a Children's Cancer Study Group Report.
    Chard RL; Krivit W; Bleyer WA; Hammond D
    Cancer Treat Rep; 1979; 63(11-12):1755-9. PubMed ID: 294306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
    Rankin EM; Harvey C; Knight RK; Rubens RD
    Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy in childhood malignancies.
    Koch K; Bloom GE; Wolfson SL
    J Fla Med Assoc; 1971 Nov; 58(11):24-35. PubMed ID: 4330159
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early phase II trial of bestrabucil in hematological malignancies].
    Nagura E; Ohno R; Yamada K; Akao Y; Naito K; Nishikawa M; Tanaka H; Shirakawa S; Ono Y; Ezaki K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2216-22. PubMed ID: 3459398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I-II trial of VM-26 (NSC-122819) in the treatment of children with late-stage leukemia.
    Rosenstock JG; Donaldson MH
    Cancer Treat Rep; 1976 Mar; 60(3):265-7. PubMed ID: 1063066
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase I study of neocarzinostatin in children with cancer.
    Rivera G; Howarth C; Aur RJ; Pratt CB
    Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of a clinical study of the preparation Lenvis in leukemias in children and adults].
    Kondrat'eva NA; Kruglova GV; Kovaleva LG; Makhonova LA; Volkova MA
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):16-21. PubMed ID: 7036140
    [No Abstract]   [Full Text] [Related]  

  • 17. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
    Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
    Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents.
    Pedersen-Bjergaard J; Hansen MM; Geisler CH; Nissen NI
    Acta Med Scand; 1980; 207(3):215-20. PubMed ID: 6989170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednimustine in acute nonlymphocytic leukemia.
    Ayulo MA; Preisler HD
    Am J Clin Oncol; 1983 Apr; 6(2):207-9. PubMed ID: 6829495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.